申请人:Vettore, LLC
公开号:US20190112275A1
公开(公告)日:2019-04-18
Disclosed herein are compounds and compositions useful in the treatment of MCT4 mediated diseases, such as proliferative and inflammatory diseases, having the structure of Formula I:
Methods of inhibition MCT4 activity in a human or animal subject are also provided.